Diagnosis and definition of treatment-resistant depression.
about
Psychological therapies for treatment-resistant depression in adultsPharmacological interventions for treatment-resistant depression in adultsTreatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as TherapyPharmacological approaches to the challenge of treatment-resistant depressionSystematic review of management for treatment-resistant depression in adolescentsA brief history of the development of antidepressant drugs: from monoamines to glutamateLight therapy for non-seasonal depression: systematic review and meta-analysisCombination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depressionPharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D studyTreatment-resistant depression: critique of current approachesAssessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP)Banking the brain. Addressing the ethical challenges of a mental-health biobankExamination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review.Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data.Energetic stress: The reciprocal relationship between energy availability and the stress response.Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review.Anxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior.Use of cortical stimulation in neuropathic pain, tinnitus, depression, and movement disorders.Medical costs and hospitalizations among patients with depression treated with adjunctive atypical antipsychotic therapy: an analysis of health insurance claims data.Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk.In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesityTreatment-Resistant Depression Entering Remission Following a Seizure during the Course of Repetitive Transcranial Magnetic Stimulation.Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.Induction of response to psychotropic medications in depression and panic after concurrent treatment of diabetes.Biomarkers for depression: recent insights, current challenges and future prospects.Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era.Neurostimulatory and ablative treatment options in major depressive disorder: a systematic reviewA randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.Does Beta-Blockade Reduce the Risk of Depression in Patients with Isolated Severe Extracranial Injuries?Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics.Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomesLong-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder.Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: a post hoc analysis of 3 randomized, double-blind, placebo-controlled studies.Deep brain stimulation for treatment-resistant depression.Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.A randomized controlled trial of intranasal ketamine in major depressive disorder.Cognitive remediation therapy for mood disorders: rationale, early evidence, and future directions.
P2860
Q24202603-03810863-2CAC-44D5-BDBE-7F0C67263C0DQ24202611-B8BE269D-2A55-4F3B-A13F-EC3C05CB4367Q26773084-042A358C-1F56-46C5-867B-3E7B663AC14DQ26798241-0578A541-8AF0-4761-B9DE-F2121C709A78Q26865021-1B50E606-1965-4F05-9CD1-3A9ECB2AE2FBQ27028050-2B802F1A-7F2F-495F-8737-493C9A80B1A3Q28080214-79D726CA-D6E0-40D4-AC48-E06D59751763Q28084183-2F54301F-96E5-4785-9C47-BEB6D45893EBQ28269390-62BAA482-4083-4C52-B1D5-AB57B702BE2AQ28290605-358B1D2D-4D0D-44B8-B764-9C118C40DE41Q28385622-81E06F7A-84F4-4B11-B4F3-6D6D47199483Q28706268-ABA4483B-3C7C-47A0-90E1-420FB6AF6B10Q29036387-162A2463-AA4C-4A8C-ADA9-BC17207866CCQ30088250-C4215095-5EC2-4433-A8EB-1BC7EFC364B2Q30252080-41908E2B-0A8C-4FD2-945D-039E32B9EB67Q30360005-8029DB0C-68D1-4BE8-A389-C2381E22A8A7Q30470391-5FCB2837-993B-49C9-A1A5-D7D67762E29CQ30534769-E6D256D0-F61A-4064-9E66-97D7280A8005Q30585843-44F8D61E-8B83-4C68-9060-BA7DB44EFBCDQ30634882-A90FF835-ED02-48BA-A6A8-A468243D1870Q30650490-EE7C4604-6221-44DF-AE0B-393D82FB6761Q30927398-70846552-D174-4996-A1D0-3430543A045FQ30976676-9A97C08C-1485-420E-8212-B2DD26B9A481Q33167551-6CE3448C-7EEE-43C5-A41A-83A12A4E3178Q33389974-DE34A6C9-D63E-494E-8DC8-F152D492B960Q33625345-05329534-C4BB-41A5-AD6D-E068CEAB87C4Q33652385-60FF2657-58D9-4170-BC3E-C1BD5078E941Q33704099-A4A711CD-3EA5-4A49-AAF5-921860A17724Q33716723-D0B6A338-954F-46E2-A47A-CE896EAC0130Q33749527-426CC98A-A878-458D-AB9E-09137B01E44EQ33782206-37AAC043-DE7E-4297-8EB1-50AD830896C5Q33841525-59F5E40A-9D00-4140-9958-D50A2DB5F270Q33980290-BDD92388-A04A-452C-9F2D-DFAAA246C15FQ34000788-44D107A2-79B2-4225-A5DB-F2F5CCB95E54Q34027230-87B5045D-B73F-4C3B-89A1-43FF8862B662Q34027550-5C992563-556C-422E-9367-BDF4AE6F546CQ34153354-077D4C29-93E0-42E1-ABBB-4C16D7467601Q34258204-9219093D-7B14-46D2-AF2F-ADAFFB6FBAC8Q34288196-EDD8F069-BBFD-4D69-8C7A-B69726982FC7Q34350959-23BBF8CB-BBC9-4967-B9C6-A02C429C5776
P2860
Diagnosis and definition of treatment-resistant depression.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Diagnosis and definition of treatment-resistant depression.
@ast
Diagnosis and definition of treatment-resistant depression.
@en
type
label
Diagnosis and definition of treatment-resistant depression.
@ast
Diagnosis and definition of treatment-resistant depression.
@en
prefLabel
Diagnosis and definition of treatment-resistant depression.
@ast
Diagnosis and definition of treatment-resistant depression.
@en
P1476
Diagnosis and definition of treatment-resistant depression.
@en
P2093
Maurizio Fava
P304
P356
10.1016/S0006-3223(03)00231-2
P407
P577
2003-04-01T00:00:00Z